XML 23 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements Of Changes In Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Preferred Stock [Member]
Preferred Stock [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Capital Surplus
Capital Surplus
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Treasury Stock
Treasury Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjusted Balance
Non-Controlling Interest
Non-Controlling Interest
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning Balance at Dec. 31, 2019 $ 3,138,472   $ 3,142,238 $ 144,784 $ 144,784 $ 563,978 $ 563,978 $ 2,151,464 $ 2,151,464 $ 201,562   $ 205,328 $ (37,548) $ (37,548) $ 110,444 $ 110,444 $ 3,788 $ 3,788
Beginning Balance (Accounting Standards Update 2016-13) at Dec. 31, 2019   $ 3,766                 $ 3,766              
Net income 353,885                 354,057             (172)  
Other comprehensive income (loss) 220,933                           220,933      
Distributions to non-controlling interest (691)                               (691)  
Stock Redeemed or Called During Period, Value (150,000)     (144,784)           (5,216)                
Purchase of treasury stock (54,163)                       (54,163)          
Cash dividends paid on common stock (120,818)                 (120,818)                
Cash dividends paid on preferred stock (6,750)                 (6,750)                
Stock-based compensation 14,915             14,915                    
Stock Issued During Period RSAs and SARs 1,309             (24,271)         25,580          
Dividends, Common Stock, Stock (886)         25,374   294,180   (353,601)     33,161          
Balance at Dec. 31, 2020 3,399,972     0   589,352   2,436,288   73,000     (32,970)   331,377   2,925  
Net income 540,590                 530,765             9,825  
Other comprehensive income (loss) (254,297)                           (254,297)      
Distributions to non-controlling interest (1,065)                               (1,065)  
Purchase of treasury stock (129,361)                       (129,361)          
Sale of non-controlling interest of a subsidiary 0             659                 (659)  
Cash dividends paid on common stock (122,693)                 (122,693)                
Stock-based compensation 15,415             15,415                    
Stock Issued During Period RSAs and SARs 911             (21,799)         22,710          
Dividends, Common Stock, Stock (1,148)         21,452   259,331   (388,579)     106,648          
Balance at Dec. 31, 2021 3,448,324     0   610,804   2,689,894   92,493     (32,973)   77,080   11,026  
Net income 500,020                 488,399             11,621  
Other comprehensive income (loss) (1,163,944)                           (1,163,944)      
Distributions to non-controlling interest (6,361)                               (6,361)  
Purchase of treasury stock (186,622)                       (186,622)          
Cash dividends paid on common stock (127,466)                 (127,466)                
Stock-based compensation 16,995             16,995                    
Stock Issued During Period RSAs and SARs 1,905             (19,563)         21,468          
Dividends, Common Stock, Stock (1,274)         18,515   245,633   (421,806)     156,384          
Balance at Dec. 31, 2022 $ 2,481,577     $ 0   $ 629,319   $ 2,932,959   $ 31,620     $ (41,743)   $ (1,086,864)   $ 16,286